Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Trius Therapeutics Inc | Financial_Report.xls |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Trius Therapeutics Inc | d270282dex231.htm |
| EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - Trius Therapeutics Inc | d270282dex312.htm |
| EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Trius Therapeutics Inc | d270282dex321.htm |
| EX-10.7 - OFFER OF EMPLOYMENT - Trius Therapeutics Inc | d270282dex107.htm |
| 10-K - FORM 10-K - Trius Therapeutics Inc | d270282d10k.htm |
| EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Trius Therapeutics Inc | d270282dex311.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Trius Therapeutics, Inc. (the “Company”) for the period ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Schmid, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| /S/ JOHN P. SCHMID |
| John P. Schmid |
| Chief Financial Officer (Principal Financial Officer) |
March 14, 2012
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.